NEW DRUG DEVELOPMENT BY UNITED-STATES PHARMACEUTICAL FIRMS WITH ANALYSES OF TRENDS IN THE ACQUISITION AND ORIGIN OF DRUG CANDIDATES, 1963-1979

被引：17

作者：

WARDELL, WM

MAY, MS

TRIMBLE, AG

机构：

来源：

关键词：

D O I：

10.1038/clpt.1982.181

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：407 / 417

页数：11

共 10 条

[1] DIRADDO J, 1981, RATE DEV ANTICANCER
[2] EISMAN M, 1981, RES MANAGE, V21, P18
[3] Grabowski HG, 1976, DRUG REGULATION INNO
[4] HALE AB, 1978, MED HLTH CARE MARKET
[5] HANSEN R, 1981, EC COSTS FDA REGULAT
[6] DEVELOPMENT OF NEW DRUGS ORIGINATED AND ACQUIRED BY UNITED-STATES-OWNED PHARMACEUTICAL FIRMS, 1963-1976
WARDELL, WM
DIRADDO, J
TRIMBLE, AG
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 270 - 277
[7] WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P133
[8] 1980, FDA PROCESS APPROVIN
[9] [No title captured]
[10] 1980, FDA DRUG APPROVAL LE